Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication of self-administered subcutaneous furosemide for patients with HF. The ...
Vietnam Investment Review on MSN
Celltrion launches AVTOZMA subcutaneous formulation in US
INCHEON, South Korea, March 16, 2026 /PRNewswire/ -- Celltrion, Inc. today announced that AVTOZMA® (tocilizumab-anoh) subcutaneous (SC) formulation is now commercially available to patients in the ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...
Credit: Getty Images. Supervised self-injection practice in the clinic to simulate adolescents' use of an epinephrine autoinjector to manage food allergy anaphylaxis offers immediate improvements in ...
Abstract and Introduction Autonomic Reaction, the Anxiety Response, and Development of Phobic Symptoms Treatment of Self-Injection Anxiety Summary References Difficulties with self-injection, ...
If topical medications haven’t been strong enough to control your psoriasis, your dermatologist may recommend a biologic, a type of drug that targets the part of the immune system responsible for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results